PubMed

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.

Jasmer RM, Saukkonen JJ, Blumberg HM, Daley CL, Bernardo J, Vittinghoff E, King MD, Kawamura LM, Hopewell PC; Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection (SCRIPT) Study Investigators.

Ann Intern Med. 2002 Oct 15;137(8):640-7.PMID: 12379063 [PubMed - indexed for MEDLINE]Related articlesFree article

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.

Gordin F, Chaisson RE, Matts JP, Miller C, de Lourdes Garcia M, Hafner R, Valdespino JL, Coberly J, Schechter M, Klukowicz AJ, Barry MA, O'Brien RJ.

JAMA. 2000 Mar 15;283(11):1445-50.PMID: 10732934 [PubMed - indexed for MEDLINE]Related articlesFree article

Safety and completion rate of short-course therapy for treatment of latent tuberculosis infection.

Cook PP, Maldonado RA, Yarnell CT, Holbert D.

Clin Infect Dis. 2006 Aug 1;43(3):271-5. Epub 2006 Jun 22.PMID: 16804838 [PubMed - indexed for MEDLINE]Related articles

Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial.

Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, Memish Z, Khan K, Gardam M, Hoeppner V, Benedetti A, Schwartzman K.

Ann Intern Med. 2008 Nov 18;149(10):689-97.PMID: 19017587 [PubMed - indexed for MEDLINE]Related articlesFree article

Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity.

McNeill L, Allen M, Estrada C, Cook P.

Chest. 2003 Jan;123(1):102-6.PMID: 12527609 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Short-course treatment for latent tuberculosis is associated with more frequent liver injury than long-course treatment is.

[No authors listed]

Ann Intern Med. 2002 Oct 15;137(8):I32. No abstract available. PMID: 12379094 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.

Jawahar MS, Rajaram K, Sivasubramanian S, Paramasivan CN, Chandrasekar K, Kamaludeen MN, Thirithuvathas AJ, Ananthalakshmi V, Prabhakar R.

Trop Med Int Health. 2005 Nov;10(11):1090-8.PMID: 16262733 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk factors for hepatotoxicity associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection: experience from three public health tuberculosis clinics.

Lee AM, Mennone JZ, Jones RC, Paul WS.

Int J Tuberc Lung Dis. 2002 Nov;6(11):995-1000.PMID: 12475146 [PubMed - indexed for MEDLINE]Related articles

Short-course prophylaxis against tuberculosis in HIV-infected persons. A decision and cost-effectiveness analysis.

Rose DN.

Ann Intern Med. 1998 Nov 15;129(10):779-86.PMID: 9841583 [PubMed - indexed for MEDLINE]Related articlesFree article

Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment.

van Hest R, Baars H, Kik S, van Gerven P, Trompenaars MC, Kalisvaart N, Keizer S, Borgdorff M, Mensen M, Cobelens F.

Clin Infect Dis. 2004 Aug 15;39(4):488-96. Epub 2004 Jul 30.PMID: 15356811 [PubMed - indexed for MEDLINE]Related articles

Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis.

Stout JE, Engemann JJ, Cheng AC, Fortenberry ER, Hamilton CD.

Am J Respir Crit Care Med. 2003 Mar 15;167(6):824-7. Epub 2002 Nov 21.PMID: 12446275 [PubMed - indexed for MEDLINE]Related articlesFree article

[Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients]

Wada M.

Kekkaku. 2001 Jan;76(1):33-43. Review. Japanese. PMID: 11211781 [PubMed - indexed for MEDLINE]Related articles

Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.

Page KR, Sifakis F, Montes de Oca R, Cronin WA, Doherty MC, Federline L, Bur S, Walsh T, Karney W, Milman J, Baruch N, Adelakun A, Dorman SE.

Arch Intern Med. 2006 Sep 25;166(17):1863-70.PMID: 17000943 [PubMed - indexed for MEDLINE]Related articlesFree article

USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results.

Combs DL, O'Brien RJ, Geiter LJ.

Ann Intern Med. 1990 Mar 15;112(6):397-406.PMID: 2155569 [PubMed - indexed for MEDLINE]Related articles

Hepatotoxicity of pyrazinamide: cohort and case-control analyses.

Chang KC, Leung CC, Yew WW, Lau TY, Tam CM.

Am J Respir Crit Care Med. 2008 Jun 15;177(12):1391-6. Epub 2008 Apr 3.PMID: 18388355 [PubMed - indexed for MEDLINE]Related articlesFree article

[The effectiveness of pyrazinamide-containing six-month short course chemotherapy]

Wada M.

Kekkaku. 2000 Nov;75(11):665-73. Japanese. PMID: 11140090 [PubMed - indexed for MEDLINE]Related articles

Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.

Schechter M, Zajdenverg R, Falco G, Barnes GL, Faulhaber JC, Coberly JS, Moore RD, Chaisson RE.

Am J Respir Crit Care Med. 2006 Apr 15;173(8):922-6. Epub 2006 Feb 10.PMID: 16474028 [PubMed - indexed for MEDLINE]Related articlesFree article

Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons?

Gordin FM, Cohn DL, Matts JP, Chaisson RE, O'Brien RJ; Terry Beirn Community Programs for Clinical Research on AIDS; Adult AIDS Clinical Trials Group; Centers for Disease Control and Prevention.

Clin Infect Dis. 2004 Aug 15;39(4):561-5. Epub 2004 Jul 30.PMID: 15356822 [PubMed - indexed for MEDLINE]Related articles

Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.

Gao XF, Wang L, Liu GJ, Wen J, Sun X, Xie Y, Li YP.

Int J Tuberc Lung Dis. 2006 Oct;10(10):1080-90.PMID: 17044199 [PubMed - indexed for MEDLINE]Related articles

Treatment of childhood tuberculosis with a six month directly observed regimen of only two weeks of daily therapy.

Al-Dossary FS, Ong LT, Correa AG, Starke JR.

Pediatr Infect Dis J. 2002 Feb;21(2):91-7.PMID: 11840073 [PubMed - indexed for MEDLINE]Related articles